Latest 10-Q quarterly reports

Permian Basin Royalty Trust reports increased royalty income driven by a Blackbeard settlement, despite lower commodity prices.

Sativus Tech Corp. reports continued operational losses and a significant accumulated deficit in its Q1 2026 10-Q filing, raising going concern doubts.

Starry Sea Acquisition Corp reports Q1 2026 results, highlighting interest income and progress towards a business combination with Forever Young International Limited.

Capstone Companies reports continued operational losses and significant going concern doubts in its Q1 2026 10-Q filing, while exploring new business avenues.

Bodhi Tree Biotechnology Inc. reported increased revenues for the second quarter of fiscal year 2026, though the company continues to operate at a net loss.

Mentor Capital, Inc. reported increased royalty revenue and gross profit for the first quarter of 2026, alongside a wider net loss.

Trio-Tech International reports significant revenue growth in Q3 FY26 driven by its Semiconductor Back-end Solutions segment, though gross margins compressed.

Marine Petroleum Trust reports a decrease in distributable income for the nine months ended March 31, 2026, driven by lower oil prices and reduced natural gas and natural gas liquids volumes.

Steele Bancorp reports a significant increase in net income for Q1 2026, driven by the successful integration of Northumberland Bancorp and improved net interest income.

Tradewinds Universal reports a 68% revenue increase in Q1 2026, but net losses significantly widened due to increased operating expenses.

Moving iMage Technologies reports a narrower net loss in Q3 2026, driven by improved gross margins and cost controls, despite a slight dip in net sales.

Urban One, Inc. announced its first quarter 2026 financial results, reporting a 15.8% decrease in net revenue to $77.7 million, primarily driven by lower advertising sales across its segments.

Healthy Extracts Inc. announced its first quarter 2026 financial results, showcasing a significant 73% increase in revenue to $1.61 million, alongside improvements in gross profit margin.

EquipmentShare.com Inc. reported a 38% year-over-year revenue increase to $989 million for the first quarter of 2026, driven by strong performance in equipment rental and platform services.

YHN Acquisition I Limited reports Q1 2026 financial results, detailing operational costs, income from investments, and ongoing progress towards its business combination with Mingde Technology Limited.

Pulse Biosciences reports first product revenue in Q1 2026, driven by Vybrance System, while advancing cardiac programs and managing operational expenses.

XTI Aerospace's Q1 2026 Form 10-Q details a significant strategic pivot towards Unmanned Aircraft Systems (UAS) and Autonomous Defense Systems (ADS), with substantial revenue generated from the recent Drone Nerds acquisition.

Curanex Pharmaceuticals reports Q1 2026 results, highlighting significant R&D investment and progress towards IND submission for Phyto-N, while addressing Nasdaq bid price concerns.

HCM III Acquisition Corp. reports Q1 2026 net income of $1.72 million, primarily from interest income, while continuing its search for a business combination.

USA Rare Earth, Inc. reported a net loss of $68.1 million for Q1 2026, driven by significant investments in its mine-to-magnet strategy and substantial progress on strategic acquisitions, including the proposed Serra Verde and Carester SAS deals.

National Vision Holdings reported a 6.6% increase in total net revenue for the first quarter of fiscal year 2026, driven by comparable store sales growth and strategic pricing initiatives.

Candel Therapeutics, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing progress in its clinical-stage biopharmaceutical development and financial performance.

QHSLab, Inc. reported Q1 2026 results with a 13% increase in revenue driven by its Integrated Service Program, despite a net loss.

Non-Invasive Monitoring Systems, Inc. reports increased G&A expenses and net loss for Q1 2026, primarily due to merger-related professional fees, while facing substantial doubt about its ability to continue as a going concern.

MeiraGTx Holdings plc filed its Q1 2026 Form 10-Q, detailing a net loss of $46.3 million and strategic advancements in its gene therapy pipeline, including the reacquisition of bota-vec.

Synergy CHC Corp. reported a significant decrease in revenue for the first quarter of 2026, driven by lower product sales, alongside an increased net loss.

Cingulate Inc. reported a net loss of $9.3 million for Q1 2026, with significant increases in general and administrative expenses, while maintaining sufficient cash for operations into early 2027.

Benitec Biopharma Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing progress in its OPMD therapeutic development and financial position.

Keros Therapeutics reports a net loss of $23.7 million for Q1 2026, a significant decrease from the prior year's net income, primarily due to the absence of a large upfront licensing payment.

Algorhythm Holdings reports a significant increase in net sales driven by its SemiCab AI logistics business, alongside a reduction in net loss for the first quarter of 2026.